Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Horizon Therapeutics
(NQ:
HZNP
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 5, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Horizon Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
3 Dow Stocks With Above-Average Dividends Yields to Buy in April
April 03, 2023
Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now.
Via
The Motley Fool
This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips
March 30, 2023
T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment.
Via
The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $7,500 Today
March 15, 2023
Via
Benzinga
Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry
March 13, 2023
When billionaires jump on the same trend, it’s important for investors to take notice. The pieces often don’t come together immediately, but these investors have millions of dollars in resources...
Via
Benzinga
Horizon Therapeutics' Debt Overview
March 06, 2023
Via
Benzinga
7 Over-$100 Stocks That Are Worth Every Penny
March 03, 2023
To get most of the best-known stocks, you have to be prepared to pay at least $100 per share. Here are seven stocks to buy.
Via
InvestorPlace
Here's How Much You Would Have Made Owning Horizon Therapeutics Stock In The Last 5 Years
March 02, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
Amgen Sinks On Mixed Earnings As 2023 Guidance Comes Up Short
January 31, 2023
Amgen reported lighter-than-expected earnings, but sales beat forecasts.
Via
Investor's Business Daily
Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry
February 23, 2023
When billionaires jump on the same trend, it’s important for investors to take notice. The pieces often don’t come together immediately, but these investors have millions of dollars in resources...
Via
Benzinga
Nearly One-Third of Billionaire George Soros' Portfolio Is Invested in These 10 Stocks
February 22, 2023
One of Soros' top 10 holdings looks especially attractive right now.
Via
The Motley Fool
Why Billionaires Paul Tudor Jones and George Soros Bought Up Horizon (HZNP) Stock
February 15, 2023
Two well-regarded billionaire investors -- George Soros and Paul Tudor Jones -- bought Horizon (HZNP) stock last quarter.
Via
InvestorPlace
Billionaires Loaded Up on These 3 Stocks in the Fourth Quarter of 2022
February 15, 2023
Billionaire-led investing firms scooped up shares of Paramount Global, Bank of America, and Horizon Therapeutics in Q4.
Via
The Motley Fool
Horizon Therapeutics Touts Positive Data From Mid-Stage Study For Immune System Disorder
January 18, 2023
Via
Benzinga
$1000 Invested In Horizon Therapeutics 5 Years Ago Would Be Worth This Much Today
January 10, 2023
Via
Benzinga
$100 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth This Much Today
December 27, 2022
Via
Benzinga
A Bullish Sign Appears On Horizon Therapeutics's Chart
December 27, 2022
Via
Benzinga
Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review
February 03, 2023
The major indexes continued to run despite mixed-to-weak earnings.
Via
Investor's Business Daily
Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline
February 01, 2023
Via
Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
January 31, 2023
Via
Benzinga
3 Biotech Companies to Watch in 2023
January 06, 2023
These biotech companies to watch are remarkably strong businesses that offer healthy upside potential as we head into a new year.
Via
InvestorPlace
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
January 06, 2023
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.
Via
InvestorPlace
5 Most Expensive Health Care Stocks You Should Worry About
January 03, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
December 24, 2022
For these companies' shareholders, it may be tempting to take profits right now. But both stocks can keep growing for a while.
Via
The Motley Fool
How Did 2022’s Most Loved Stocks By Analysts Fare?
December 24, 2022
Looking at just stocks with coverage from at least eight analysts, the average Russell 1,000 stock had about 59% buy ratings at the start of 2022.
Via
Talk Markets
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
December 23, 2022
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Analyzing Horizon Therapeutics's Short Interest
December 22, 2022
Horizon Therapeutics's (NASDAQ:HZNP) short percent of float has fallen 7.07% since its last report. The company recently reported that it has 6.49 million shares sold short, which is 2.89% of all...
Via
Benzinga
2 No-Brainer Biotech Stocks to Buy Right Now
December 22, 2022
Vertex Therapeutics and Amgen have the building blocks for long-term success.
Via
The Motley Fool
Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks
December 21, 2022
Even if interest rates go up, you likely won't need to worry about these stocks.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.